MiR-31-5p from Placental and Peripheral Blood Exosomes is a Potential Biomarker to Diagnose Preeclampsia

Overview

Journal Hereditas

Specialty Genetics

Date 2022 Sep 19

PMID 36123601

Authors

Gang Zou

Qingfang Ji

Zixiang Geng

Xiling Du

Lingyan Jiang

Te Liu

Affiliations

Soon will be listed here.

Abstract

Background: Preeclampsia, a multisystem disorder of unknown etiology, is one of the leading causes of maternal and perinatal morbidity and mortality. Identifying sensitive, noninvasive markers can aid its prevention and improve prognosis. microRNAs (miRs), which function as negative regulators of gene expression, are closely related to preeclampsia occurrence and development. Herein we investigated the relationship between the DLK1-Dio3 imprinted miR cluster derived from placental and peripheral blood exosomes of pregnant women with preeclampsia and routine clinical diagnostic indicators, and also determined its potential as a noninvasive diagnostic marker.

Methods: Exosomes were extracted from the placenta and peripheral blood of pregnant women with preeclampsia.

Results: qPCR data indicated that the expression level of miRs, such as miR-134, miR-31-5p, miR-655, miR-412, miR-539, miR-409, and miR-496, in pregnant women with preeclampsia was significantly lower than that in healthy controls; miR-31-5p expression was the most different. Gene ontology analysis predicted that genes negatively regulated by miR-31-5p were mainly enriched in cellular entity, cellular process, and binding; moreover, Kyoto Encyclopedia of Genes and Genomes pathway analyses indicated that genes were involved in gonadotropin-releasing hormone receptor pathway and other signaling pathways. Correlation analysis revealed that miR-31-5p was significantly negatively correlated with clinical indicators of preeclampsia, such as systolic and diastolic pressure, lactate dehydrogenase, and proteinuria.

Conclusion: We believe that exosome-derived miR-31-5p can serve as an effective and sensitive biomarker to determine the course of preeclampsia in pregnant women.

Citing Articles

Understanding the role of soluble proteins and exosomes in non-invasive urine-based diagnosis of preeclampsia.

Kim T, Kallubhavi Choodinatha H, Kim K, Shin K, Kim H, Park J Sci Rep. 2024; 14(1):24117.

PMID: 39406891 PMC: 11482518. DOI: 10.1038/s41598-024-75080-2.

Placenta Extracellular Vesicles: Messengers Connecting Maternal and Fetal Systems.

Rosenfeld C Biomolecules. 2024; 14(8).

PMID: 39199382 PMC: 11352387. DOI: 10.3390/biom14080995.

DNMT1 driven by mouse amniotic fluid mesenchymal stem cell exosomes improved corneal cryoinjury via inducing microRNA-33 promoter DNA hypermethylation modification in corneal epithelium cells.

Xu W, Fei X, Cui Z, Pan D, Liu Y, Liu T Hum Cell. 2024; 37(4):1091-1106.

PMID: 38782857 DOI: 10.1007/s13577-024-01082-x.

Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia.

Gal L, Fothi A, Orosz G, Nagy S, Than N, Orban T Front Immunol. 2024; 15:1321191.

PMID: 38455065 PMC: 10917917. DOI: 10.3389/fimmu.2024.1321191.

The Role of ncRNAs in the Immune Dysregulation of Preeclampsia.

Mora-Palazuelos C, Villegas-Mercado C, Avendano-Felix M, Lizarraga-Verdugo E, Romero-Quintana J, Lopez-Gutierrez J Int J Mol Sci. 2023; 24(20).

PMID: 37894897 PMC: 10607488. DOI: 10.3390/ijms242015215.

References

Edwards C, Mungall A, Matthews L, Ryder E, Gray D, Pask A . The evolution of the DLK1-DIO3 imprinted domain in mammals. PLoS Biol. 2008; 6(6):e135. PMC: 2408620. DOI: 10.1371/journal.pbio.0060135. View

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

Salsoso R, Farias M, Gutierrez J, Pardo F, Chiarello D, Toledo F . Adenosine and preeclampsia. Mol Aspects Med. 2017; 55:126-139. DOI: 10.1016/j.mam.2016.12.003. View

Peng L, Chen Y, Shi S, Wen H . Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management. Stem Cell Res Ther. 2022; 13(1):25. PMC: 8785577. DOI: 10.1186/s13287-021-02696-w. View

He C, Zheng S, Luo Y, Wang B . Exosome Theranostics: Biology and Translational Medicine. Theranostics. 2018; 8(1):237-255. PMC: 5743472. DOI: 10.7150/thno.21945. View

Yen Y, Hsieh W, Tsai Y, Lu Y, Liau E, Hsu H . locus-derived lncRNAs perpetuate postmitotic motor neuron cell fate and subtype identity. Elife. 2018; 7. PMC: 6221546. DOI: 10.7554/eLife.38080. View

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

Lyu L, Yang W, Yao J, Wang H, Zhu J, Jin A . The diagnostic value of plasma exosomal for hepatocellular carcinoma. Biomark Med. 2021; 15(5):359-371. DOI: 10.2217/bmm-2020-0476. View

Cheng W, Liu T, Wan X, Gao Y, Wang H . MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J. 2012; 279(11):2047-59. DOI: 10.1111/j.1742-4658.2012.08589.x. View

10.

Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R . Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014; 10(8):466-80. PMC: 5893150. DOI: 10.1038/nrneph.2014.102. View

11.

Liu T, Jing F, Huang P, Geng Z, Xu J, Li J . Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let-7 family microRNAs. Cell Prolif. 2021; 54(8):e13089. PMC: 8349654. DOI: 10.1111/cpr.13089. View

12.

Schonfelder G, Fuhr N, Hadzidiakos D, John M, Hopp H, Paul M . Preeclampsia is associated with loss of neuronal nitric oxide synthase expression in vascular smooth muscle cells of the human umbilical cord. Histopathology. 2004; 44(2):116-28. DOI: 10.1111/j.1365-2559.2004.01806.x. View

13.

Crescitelli R, Lasser C, Lotvall J . Isolation and characterization of extracellular vesicle subpopulations from tissues. Nat Protoc. 2021; 16(3):1548-1580. DOI: 10.1038/s41596-020-00466-1. View

14.

Chang C, Liu T, Huang Y, Qin W, Yang H, Chen J . MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A. Gene. 2017; 605:99-107. DOI: 10.1016/j.gene.2016.12.030. View

15.

Pritchard C, Cheng H, Tewari M . MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012; 13(5):358-69. PMC: 4517822. DOI: 10.1038/nrg3198. View

16.

Zhang H, Zheng J, Shen H, Huang Y, Liu T, Xi H . Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs. Genet Test Mol Biomarkers. 2017; 22(1):43-50. DOI: 10.1089/gtmb.2017.0179. View

17.

Mo C, Wu F, Tai K, Chang W, Chang K, Kuo H . Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines. Stem Cell Res Ther. 2015; 6:1. PMC: 4417332. DOI: 10.1186/scrt535. View

18.

Lin S, Coan P, da Rocha S, Seitz H, Cavaille J, Teng P . Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region. Development. 2006; 134(2):417-26. DOI: 10.1242/dev.02726. View

19.

Reilly S, Liu X, Carnicer R, Rajakumar T, Sayeed R, Krasopoulos G . Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man. Lancet. 2015; 385 Suppl 1:S82. DOI: 10.1016/S0140-6736(15)60397-X. View

20.

da Rocha S, Edwards C, Ito M, Ogata T, Ferguson-Smith A . Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet. 2008; 24(6):306-16. DOI: 10.1016/j.tig.2008.03.011. View